Joseph A. O’Donoghue

机构：Memorial Sloan Kettering Cancer Center · ORCID：0000-0002-2761-0015

发表论文 236 篇 · 总被引 6920 次 · h-index 49

代表论文

Imaging with [89Zr]Zr-DFO-SC16.56 anti-DLL3 antibody in patients with high-grade neuroendocrine tumours of the lung and prostate: a phase 1/2, first-in-human trial (2024 · The Lancet Oncology · 被引 56)
First-in-Human Evaluation of Site-Specifically Labeled 89 Zr-Pertuzumab in Patients with HER2-Positive Breast Cancer (2024 · Journal of Nuclear Medicine · 被引 49)
How Can Radiopharmaceutical Therapies Reach Their Full Potential? Improving Dose Reporting and Phase I Clinical Trial Design (2024 · Journal of Clinical Oncology · 被引 36)
Lesion Dosimetry for [ 177 Lu]Lu-PSMA-617 Radiopharmaceutical Therapy Combined with Stereotactic Body Radiotherapy in Patients with Oligometastatic Castration-Sensitive Prostate Cancer (2023 · Journal of Nuclear Medicine · 被引 28)
Lesion Absorbed Dose–Response Relationship in Patients with Metastatic Castration-Resistant Prostate Cancer Undergoing [ 177 Lu]Lu-PSMA-617 Radiopharmaceutical Therapy (2025 · Journal of Nuclear Medicine · 被引 15)
A Phase 0 Study to Assess the Biodistribution and Pharmacokinetics of a Radiolabeled Antibody Targeting Human Kallikrein 2 in Participants with Metastatic Castration-Resistant Prostate Cancer (2024 · Journal of Nuclear Medicine · 被引 10)